Who we are

Cardisio GmbH, founded in 2016 and headquartered in Frankfurt am Main, is committed to the early detection of heart disease. Cardisiography (CSG) is a procedure that quickly, precisely and non-invasively detects pathological patterns that are indicative of heart disease. Cardisiography is now used in a multitude of practices and clinics, paving the way for simple and reliable early heart disease detection. In addition to its headquarters, Cardisio has a location in Berlin, as well as many internationally active sales partners in various countries.

Vision

In Cardisio’s future, everyone has access to a scientifically proven, highly accurate and non-invasive screening procedure for heart disease that is easy to use, exam-independent and affordable. We aim to reduce cardiac deaths, complications and healthcare costs by providing more effective heart exams globally.